Alnylam Pharmaceuticals Inc (ALNY)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ALNY? Forum Prognose

Finanzdaten der Alnylam Pharmaceuticals Inc-Aktie (ALNY)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	12.17% 1,097.03	1,249.03	773.69	594.19	593.17
Cost Of Revenue	35.74% 267.72	197.23	142.03	70.18	102.65
Gross Profit	21.15% 829.31	1,051.80	631.66	524.01	490.52
Operating Expenses	2.02% 697.59	683.81	647.86	505.93	595.68
Benefits Costs and Expenses	7.34% 935.90	1,010.06	809.05	635.78	787.12
Costs And Expenses	9.56% 965.32	881.04	789.89	576.11	698.33
Operating Income/Loss	64.21% 131.72	367.98	-16.20	18.08	-105.16
Nonoperating Income/Loss	64.77% -45.46	-129.01	-19.16	-20.45	-88.80
Income/Loss From Continuing Operations Before Tax	63.90% 86.26	238.97	-35.36	-2.368	-193.96
Income Tax Expense/Benefit, Deferred	585.35% -27.17	5.598	9.735	9.639	-
Income Tax Expense/Benefit	108.68% -25.28	-12.12	30.92	15.88	-110.19
Income/Loss From Continuing Operations After Tax	69.39% 76.86	251.08	-66.28	-2.368	-83.76
Net Income/Loss	55.58% 111.54	251.08	-66.28	-18.25	-83.76
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.69% 0.414	131.45	130.63	129.68	0.492
Diluted Average Shares	99.61% 0.538	137.35	130.63	129.68	0.492
Basic Earnings Per Share	56.02% 0.84	1.91	-0.51	-0.14	-0.65
Diluted Earnings Per Share	55.43% 0.82	1.84	-0.51	-0.14	-0.65
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ARGX

$700.45

1.19%

ONC

$284.05

0.44%

INSM

$139.50

0.01%

BNTX

$91.19

1.21%

MRNA

$52.56

1.55%